Expanding use of embolic protection devices

Martin G Radvany1, Michael Wholey

  • 1Department of Radiology, Brooke Army Medical Center, Fort Sam Houston, Texas.

Insights

Embolic protection devices, initially for bypass grafts, are now widely used in carotid interventions and expanding to renal arteries and lower extremities to prevent dangerous emboli.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Embolic protection devices (EPDs) were first developed to manage risks associated with aorto-coronary bypass graft stenosis.
  • The significant risk of atheroembolism in bypass graft interventions necessitated the development of EPDs.
  • Their use is well-established in this context.

Purpose of the Study:

  • To review the fundamental principles of embolic protection devices.
  • To explore the expanding applications of EPDs across various vascular beds.
  • To discuss the clinical utility of EPDs based on literature and institutional experience.

Main Methods:

  • Literature review of embolic protection device principles and applications.
  • Analysis of institutional experience with EPDs in diverse vascular interventions.
  • Synthesis of data regarding EPD efficacy and safety in different anatomical locations.

Main Results:

  • EPDs are well-accepted for saphenous vein aorto-coronary bypass graft stenosis due to high atheroembolism risk.
  • Use of EPDs is also well-accepted in carotid arterial interventions due to severe consequences of cerebral embolization.
  • Current use of EPDs is extending to other critical vascular areas, including renal arteries and lower extremities.

Conclusions:

  • Embolic protection devices have proven efficacy and acceptance in coronary and carotid interventions.
  • The application of EPDs is progressively broadening to encompass peripheral vascular beds.
  • EPDs represent a crucial tool in mitigating embolic events across multiple arterial systems.

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...